Skip to main content
Kane Biotech Inc. logo

Kane Biotech Inc. — Investor Relations & Filings

Ticker · KNE ISIN · CA4838092084 TSXV Manufacturing
Filings indexed 582 across all filing types
Latest filing 2023-09-20 Regulatory Filings
Country CA Canada
Listing TSXV KNE

About Kane Biotech Inc.

https://kanebiotech.com/

Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of proprietary technologies designed to prevent and remove microbial biofilms, which are a major contributor to chronic infections and impaired healing. The company holds extensive intellectual property related to biofilm formation and dispersal mechanisms, utilizing proprietary technologies such as DispersinB® and coactiv+®. Its primary commercial focus is advanced wound care, where products like the revyve® Antimicrobial Wound Gel and Spray are designed to disrupt biofilms and promote healing. The product pipeline also includes surgical and dermatological applications for both human and animal health.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, underwriter information, distribution dates, purchaser information, types of securities distributed, compensation related to the distribution, and directors and officers of the issuer. The form is a regulatory filing related to exempt distributions of securities under Canadian securities law, specifically referencing National Instrument 45-106. It is not a financial report like an annual or interim report, nor is it an earnings release or a management discussion. It is a formal regulatory filing reporting on exempt securities distribution activity. Therefore, the document fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory filings that do not fit other specific categories.
2023-09-20 English
Material change report - English.pdf
Regulatory Filings
2023-09-12 English
News release - English.pdf
Regulatory Filings
2023-09-12 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-08-29 English
Interim MD&A - English.pdf
Regulatory Filings
2023-08-29 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-08-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.